Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adrenergic blocker
adverse drug reaction
alcohol block, subarachnoid
alpha adrenergic blocker
amenorrhea
autonomic dysfunction
benign essential tremor
beta adrenergic blocker
cauda equina
cauda equina, lesion of
cerebral ischemia
dibenzyline
diplopia, monocular
drug induced neurologic disorders
ejaculation
ejaculation, retrograde
erection
fertility
guanethidine
headache
headache, post traumatic
headache, vascular
Horner's syndrome
hyperhidrosis
impotence
labetalol
midodrine
muscle pain
myopathy
myopathy, toxic
myositis
neuropathy, peripheral
orgasm
orthostatic hypotension
orthostatic hypotension, idiopathic
orthostatic hypotension, treatment of
pregnancy, neurologic complications in
priapism
propranolol
ptosis
pupil, abnormality in neurologic disorders
pupil, dilated, unilateral
review article
rhizotomy
rhizotomy, phenol
risk factors
sexual dysfunction in neurologic disease
sexual intercourse
Shy-Drager syndrome
spinal cord, injury of
spinal cord, injury, functional capacity of patient with
spinal cord, injury, sexual dysfunction in
steroid
subarachnoid hemorrhage
subarachnoid hemorrhage, treatment of
sympathectomy
sympatholytic agent
syncope
trauma
treatment of neurologic disorder
tremor
vasopressin
Showing articles 0 to 50 of 3492 Next >>

Treatment of Postural Hypotension
JNNP 65:285-289, Mathias,C.J.&Kimber,J.R., 1998

Beneficial Effects of Adrenergic Blockage in Patients With Subarachnoid Hemorrhage
BMJ 284:1661-1663, Walter,P.,et al, 1982

Labetalol-induced Toxic Myopathy
BMJ 282:1824-1825, Teicher,A.,et al, 1981

Midodrine, A New Agent in the Management of Idiopathic Orthostatic Hypotension & Shy-Drager Syndrome
Mayo Clin Proc 56:429-433, Schirger,A.,et al, 1981

Sexual Dysfunction in Neuro. Disease
Med Aspects of Human Sex April, 1976, p. 7., Horenstein,S., 1976

Posttraumatic Dysautonomic Cephalgia
Arch Neurol 32:649, Vijayan,N.,et al, 1975

Non-Beta Blocking Action of Propranolol
NEJM 293:988, Koch-Weser,J., 1975

Ptosis-Toxiocology of the Eye
p 814, , 1974

Monocular Diplopia:Its Characteristics & Response to Guanethidine
Am J Ophthalmol 63:459, Hales,R., 1967

A 41-Year-Old Man with Steroid-Responsive Hemiparesis
Neurol 106:e214088, Obaidi,Z.A.,et al, 2026

Progressive Quadriparesis and Falls in a 66-Year-Old Man With Longstanding Human Immunodeficiency Virus
Neurol 106:e214621, Ong,B.A. & Carlson,A.K., 2026

Intravenous Thrombolysis Use in the Late Time Window Before Interhospital Transfer for Thrombectomy
JAMA Neurol 83:60-67, Seners,P.,et al, 2026

Intravenous Thrombolysis Use Before Inter-Facility Transfer for Thrombectomy:Association with Efficacy and Safety Outcomes
Ann Neurol 98:871-880, Seners,P.,et al, 2025

Effectiveness and Safety of IV Thrombolysis Before Hospital Transfer for Thrombectomy in Patients With Basilar Artery Occlusion
Neurol 105:e214355, Liebart,S.,et al, 2025

Upbeat Nystagmus From Dorsolateral Pontine Hemorrhagic Transformation
Neurol 106:e214467, Chen,H. & Li, J., 2025

Chasing the New Dragon, Toxic Spongiform Leukoencephalopathy with Chronic Fentanyl Inhalation
Neurol 106:e214517, Maisenbacher,M. & Jayagopal, L.A., 2025

Endovascular Thrombectomy for Extracranial Internal Carotid Artery Occlusions with Large Ischemic Strokes
Neurol 104:e210269, Ortega-Gutierrez,S.,et al, 2025

Endovascular Therapy for Patients with Low NIHSS Scores and Large Vessel Occlusion in the 6- to 24-Hour Window
Neurol 104:e213442, Marto,J.P.,et al, 2025

Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025

Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025

Alteplase for Posterior Circulation Ischemic Stropke at 4.5 to 24 Hours
NEJM 392:1288-1296, Yan,S.,et al, 2025

"Innumerable" lesion burden on brain MRI - a diagnostic approach
Diagnosis doi.org/10.1515/dx- 2025-2029, Finelli,P.F., 2025

Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion
NEJM 392:1385-1395,1440, Goyal,lM.,et al, 2025

Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels
NEJM 392:1374-1384,1440, Psychogios,M.,et al, 2025

Chronic Neuropsychiatric Sequelae Associated with Kambo Intoxication
JAMA Neurol 82:418-419, Jauregui,R.,et al, 2025

Endovascular Thrombectomy for Large Ischemic Core Stroke, A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Neurol 104:e213443, Liu,C.,et al, 2025

A 69-Year-Old Woman with Ophthalmoplegia
Neurol 104:e213763, Yu, H & Frey, J, 2025

Risk of Dementia in Individuals with Emergency Department Visits or Hospitalizations Due to Cannabis
JAMA Neurol 82:570-579, Myran,D.T.,et al, 2025

A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
NEJM 392:2309-2320, Nowak,R.J.,et al, 2025

Myasthenia Gravis - Redemption for B-Cell Depletion
NEJM 392:2382-2384, Wolfe,G.I. & Shelly,S., 2025

Efficacy and Safety of Ofatumumab Treatment for Anti-NMDA Receptor Autoimmune Encephalitis (OFF-AE): A Prospective, Multicenter Cohort Study
Ann Neurol 98:80-92, Guo,K.,et al, 2025

Intravenous Tenecteplase before Thrombectomy in Stroke
NEJM 393:139-150, Qiu,Z.,et al, 2025

Intra-Arterial Thrombolysis Following Endovascular Recanalization for Large Vessel Occlusion Stroke
Neurol 105: e213842, Jiang,X.,et al, 2025

Clinicopathological Conference, Powasan Virus Encephalitis
NEJM 393:176-184, Case 19-2025, 2025

Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation
NEJM 392:2403-2412, 2473, Kharbanda,R.K.,et al, 2025

Real-World Evidence of Brexpiprazole Use and 6-Month Mortality, Hospitalization, and Emergency Department Visits Among Persons with Dementia
Neurol 105: e213717, Zissimopoulos, J.,et al, 2025

Frequency, Risk Factors, and Outcomes of Strokes in Patients with Primary Glioma After Cranial Radiation
Neurol 105:e213902, Ryan,D.,et al, 2025

Endovascular Treatment in Acute Ischemic Stroke Due to Occlusion of Medium or Distal Vessels
Neurol 105:e214015, Palaiodimou,L.,et al, 2025

The Multifactorial Nature of Ischemic Stroke in Malignancy
Stroke 56:e303-e306, Doyle,C.L.,et al, 2025

Clinicopathologic Features, Pathogenesis, and Treatment of Monoclonal Gammopathy-Associated Myopathies
Neurol 105:213101, Soontrapa,P.,et al, 2025

Early Tirofiban Infusion after Intravenous Thrombolysis for Stroke
NEJM 393:1191-1201, Tao,C.,et al, 2025

New Treatments for Migraine: CGRP Monoclonal Antibodies, Gepants, and Ditans
BMJ 390:e085564, Burch, R. & Rittenberg, E., 2025

Neuroimaging Findings in Children and Young Adults with Neurotoxicity after CAR T-Cell Therapy for B-Cell Malignancies
Neurol 105:e214086, McGuire,J.L.,et al, 2025

Idiopathic Intracranial Hypertension
NEJM 393:1409-1414, Horton,J.C., 2025

Endovascular Thrombectomy Versus Best Medical Therapy for Large Vessel Occlusion Stroke Beyond 24 Hours: A Systematic Review and Meta-Analysis
Stroke 56:3127-3137, Rodriguez-Caliemnes,A.,et al, 2025

Early Thrombolysis and Outcomes in Central Retinal Artery Occlusion:An Individual Participant Data Meta-Analysis
Stroke 56:3175-3186, Xie,J.S.,et al, 2025

Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients with Moyamoya Disease
Neurol 104:e210243, Chen,H.,et al, 2025

Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025

Clinicopathologic Conference, Posterior Reversible Encephalopathy Syndrome Due to Sickle Cell Disease
NEJM 392:268-276, Case 2-2025, 2025



Showing articles 0 to 50 of 3492 Next >>